UC Davis researchers have synthesized ibogaine and its analogues from inexpensive chemicals, overcoming challenges in ...

Researchers have identified the CH25H enzyme in cancerous lymphatic cells as a key regulator of immune cell activity.

Leah Sabin shares her STEM journey, from studying viruses to advancing genetic medicine, and the potential of genetic therapies.

Experts discuss the challenges and breakthroughs in iPSC-based therapies, including scalability, safety, and regulatory ...

CN Bio enhances hepatotoxicity testing to improve drug safety, reducing the risk of costly clinical trial failures.

Scientists discover novel enhancers linked to neuropsychiatric diseases, paving the way for new drug discovery opportunities.

Explore how Capgemini's innovative approach is enhancing the bioeconomy through generative AI in protein engineering.

Integrating genomics and AI is key to increasing the probability of success and accelerating the delivery of treatments to ...

Discover the breakthrough research on food allergies, identifying the role of mucosal mast cells in triggering the immune ...

Dr Jason Bock and CTMC are transforming cell therapy development with genetic engineering and a unique patient-adjacent ...

Grifols' Chronos-PD initiative leverages its plasma repository to identify biomarkers for Parkinson’s disease.

A new study identifies 58 drug targets for heart failure, offering potential for more effective, targeted treatments for its ...